Literature DB >> 15851670

Varicella-zoster virus infection of human dorsal root ganglia in vivo.

Leigh Zerboni1, Chia-Chi Ku, Carol D Jones, James L Zehnder, Ann M Arvin.   

Abstract

Varicella-zoster virus (VZV) causes varicella and establishes latency in sensory ganglia. VZV reactivation results in herpes zoster. We developed a model using human dorsal root ganglion (DRG) xenografts in severe combined immunodeficient (SCID) mice to investigate VZV infection of differentiated neurons and satellite cells in vivo. DRG engrafted under the kidney capsule and contained neurons and satellite cells within a typical DRG architecture. VZV clinical isolates infected the neurons within DRG. At 14 days postinfection, VZ virions were detected by electron microscopy in neuronal cell nuclei and cytoplasm but not in satellite cells. The VZV genome copy number was 7.1 x 10(7) to 8.0 x 10(8) copies per 10(5) cells, and infectious virus was recovered. This initial phase of viral replication was followed within 4-8 weeks by a transition to VZV latency, characterized by the absence of infectious virus release, the cessation of virion assembly, and a reduction in VZV genome copies to 3.7 x 10(5) to 4.7 x 10(6) per 10(5) cells. VZV persistence in DRG was achieved without any requirement for VZV-specific adaptive immunity and was associated with continued transcription of the ORF63 regulatory gene. The live attenuated varicella vaccine virus exhibited the same pattern of short-term replication, persistence of viral DNA, and prominent ORF63 transcription as the clinical isolates. VZV-infected T cells transferred virus from the circulation into DRG, suggesting that VZV lymphotropism facilitates its neurotropism. DRG xenografts may be useful for investigating neuropathogenic mechanisms of other human viruses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15851670      PMCID: PMC1088374          DOI: 10.1073/pnas.0501045102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Varicella-Zoster virus gene expression in latently infected rat dorsal root ganglia.

Authors:  P G Kennedy; E Grinfeld; S Bontems; C Sadzot-Delvaux
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

2.  Comparison of herpes simplex virus reactivation in ganglia in vivo and in explants demonstrates quantitative and qualitative differences.

Authors:  N M Sawtell; R L Thompson
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Varicella-zoster virus open reading frame 2 encodes a membrane phosphoprotein that is dispensable for viral replication and for establishment of latency.

Authors:  Hitoshi Sato; Lesley Pesnicak; Jeffrey I Cohen
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Phosphorylation of varicella-zoster virus IE63 protein by casein kinases influences its cellular localization and gene regulation activity.

Authors:  Sébastien Bontems; Emmanuel Di Valentin; Laurence Baudoux; Bernard Rentier; Catherine Sadzot-Delvaux; Jacques Piette
Journal:  J Biol Chem       Date:  2002-03-23       Impact factor: 5.157

5.  Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.

Authors:  Leigh Zerboni; Stewart Hinchliffe; Marvin H Sommer; Hideki Ito; Jaya Besser; Shaye Stamatis; Jason Cheng; Daniel Distefano; Nikolai Kraiouchkine; Alan Shaw; Ann M Arvin
Journal:  Virology       Date:  2005-02-05       Impact factor: 3.616

6.  Physical and functional interaction between the varicella zoster virus IE63 and IE62 proteins.

Authors:  Jennifer M Lynch; Terri K Kenyon; Charles Grose; John Hay; William T Ruyechan
Journal:  Virology       Date:  2002-10-10       Impact factor: 3.616

7.  Interactions among structural proteins of varicella zoster virus.

Authors:  M Spengler; N Niesen; C Grose; W T Ruyechan; J Hay
Journal:  Arch Virol Suppl       Date:  2001

8.  The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo.

Authors:  Armin Baiker; Christoph Bagowski; Hideki Ito; Marvin Sommer; Leigh Zerboni; Klaus Fabel; John Hay; William Ruyechan; Ann M Arvin
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Varicella-zoster virus DNA in cells isolated from human trigeminal ganglia.

Authors:  Myron J Levin; Guang-Yun Cai; Michael D Manchak; Lewis I Pizer
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Varicella-zoster virus gene 66 transcription and translation in latently infected human Ganglia.

Authors:  Randall J Cohrs; Donald H Gilden; Paul R Kinchington; Esther Grinfeld; Peter G E Kennedy
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more
  76 in total

1.  Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells.

Authors:  Jenna Christensen; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Primary varicella in an immunocompetent adult.

Authors:  Izikson Leonid; Lilly Evelyn
Journal:  J Clin Aesthet Dermatol       Date:  2009-08

3.  Role of the JNK Pathway in Varicella-Zoster Virus Lytic Infection and Reactivation.

Authors:  Sravya Kurapati; Tomohiko Sadaoka; Labchan Rajbhandari; Balaji Jagdish; Priya Shukla; Mir A Ali; Yong Jun Kim; Gabsang Lee; Jeffrey I Cohen; Arun Venkatesan
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

4.  Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.

Authors:  Chantelle Hood; Anthony L Cunningham; Barry Slobedman; Ann M Arvin; Marvin H Sommer; Paul R Kinchington; Allison Abendroth
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 5.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

Review 6.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

7.  Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection.

Authors:  Barbara Berarducci; Jaya Rajamani; Leigh Zerboni; Xibing Che; Marvin Sommer; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

8.  Varicella-Zoster Virus Activates CREB, and Inhibition of the pCREB-p300/CBP Interaction Inhibits Viral Replication In Vitro and Skin Pathogenesis In Vivo.

Authors:  Sylvie François; Nandini Sen; Bryan Mitton; Xiangshu Xiao; Kathleen M Sakamoto; Ann Arvin
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

9.  Clinical and molecular aspects of varicella zoster virus infection.

Authors:  Don Gilden; Maria A Nagel; Ravi Mahalingam; Niklaus H Mueller; Elizabeth A Brazeau; Subbiah Pugazhenthi; Randall J Cohrs
Journal:  Future Neurol       Date:  2009-01-01

10.  Varicella-zoster virus reactivation from multiple ganglia: a case report.

Authors:  Mazyar Hashemilar; Kamyar Ghabili; Mohammadali Mohajel Shoja; Dariush Savadi-Oskouei; Hossein Keyvani
Journal:  J Med Case Rep       Date:  2009-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.